Application of promoting blood circulation and resolving blood stasis in intracerebral hemorrhage: a traditional method gradually being reconsidered
- PMID: 40151133
- PMCID: PMC11955772
- DOI: 10.19852/j.cnki.jtcm.2025.02.017
Application of promoting blood circulation and resolving blood stasis in intracerebral hemorrhage: a traditional method gradually being reconsidered
Abstract
Intracerebral hemorrhage (ICH) is a significant and growing threat to human health, with increasing incidence. Promoting blood circulation and removing blood stasis therapy (PBCRBS), a Traditional Chinese Medicine therapy, can be an adjuvant therapy to benefit patients with ICH by improving clinical efficacy. However, in theory, using PBCRBS to treat ICH carries the risk of hematoma enlargement and rebleeding, which has led to controversy over its application in ICH treatment. To demonstrate the effectiveness and safety of PBCRBS in treating ICH, this review first analyzes the pathological and physiological basis of ICH and secondly, the cascade of response after ICH and the involvement of cytokines and signaling pathways in this process. Finally, experimental and clinical studies on the treatment of ICH with PBCRBS over the past decade were retrieved from the PubMed and China National Knowledge Infrastructure databases, and the content of these studies was used to summarize commonly used herbs with PBCRBS effects and their mechanisms of action. Through analysis, hypertension has been identified as the most common cause of ICH. Heme, interleukin, reactive oxygen species, coagulation promoting particles and other induced mass effects, inflammation, oxidative stress, and coagulation cascade reactions lead to brain damage following ICH. This review includes 56 experimental studies and 83 clinical studies summarizing 28 commonly used herbs, demonstrating the positive impact of PBCRBS as an adjuvant therapy for ICH. In summary, PBCRBS appears effective and safe for treating ICH.
Keywords: cerebral hemorrhage; etiology; medicine, Chinese traditional; pathology; physiopathology; promoting blood circulation and removing blood stasis; review.
Figures
References
-
- Alqadri SL, Qureshi AI. Management of acute hypertensive response in patients with intracerebral hemorrhage. Curr Atheroscler Rep 2012; 14: 322-7. - PubMed
-
- Lei L, Jia M, Liao X, et al.. Reticular meta analysis of oral or nasal traditional Chinese patent medicines in the treatment of hypertensive intracerebral hemorrhage. Zhong Guo Zhong Yao Za Zhi 2021; 46: 2995-3006. - PubMed
-
- Hemphill JC 3rd, Greenberg SM, Anderson CS, et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American heart association /American Stroke association. Stroke 2015; 46: 2032-60. - PubMed
-
- Ni XJ, Lin H, Li H, et al.. Evidence-based practice guideline on integrative medicine for stroke 2019. J Evid Based Med 2020; 13: 137-52. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 82074378/National Natural Science Foundation of China: Study on the Intervention Mechanism of Zhilong Huoxue Tongyu Capsule in Hypertensive Myocardial Fibrosis by Regulating Transforming Growth Factor-β/Smad3/Erbb4-IR/miR29b Loop
- 2022YFS0618/Science & Technology Department of Sichuan Province: Research on the Optimization of Basic and Clinical Plans for Treating Coronary Heart Disease and Heart Failure based on Xuanfu Theory
- 2023JYJ029/Luzhou Science and Technology Bureau Project: the Mechanism of Hirudin Inhibiting AngⅡ Induced Myocardial Hypertrophy by Regulating Autophagy and NOD-like Receptor Family Pyrin Domain Containing Protein 3 Inflammasome
- 2023ZYYQ04/Southwest Medical University Project: Study on the Mechanism of Zhilong Huoxue Tongyu Capsules in Improving NOD-like Receptor Family Pyrin Domain Containing Protein 3 Inflammasome Mediated Cardiomyocyte Pyroptosis in Heart Failure by Regulating the Hippo-Yes-Associated Protein Pathway
LinkOut - more resources
Full Text Sources
Miscellaneous